Pérez-Llorca has advised Venture Capital firm Nazca Capital on its entrance into the capital of Spanish nutraceutical company Nutris as a majority shareholder
Nutris, a company specialising in the nutraceutical sector, has acquired Nazca, a leading venture capital investment firm in unlisted Spanish SMEs, as a majority shareholder through the Nazca V Fund. Headquartered in Madrid and founded in 2013, Nutris is a nutraceutical company specialising in the production of functional gummies, sold in pharmacies, herbalists and specialised shops.
The aim of Nutris has been to bring in a partner to support it in the development of an ambitious growth project, via the development of new functional projects with scientific validation in the field of health. The company plans to double its size in 3/4 years, consolidating its position in functional gummies and boosting international expansion in its functional ingredients and probiotics division, taking advantage of existing market opportunities. Nutris has managed to position itself as one of the leading manufacturers of functional gummies in Europe, achieving growth rates of 60% per year, going from a turnover of €16 million in 2020 to an estimated €25 million in 2021 and EBITDA margins of around 20%.
The project will continue to be led by Pedro de la Fuente and Inés de Santos, founding partners of the company, who have a deep knowledge of the nutraceutical sector and maintain their position as major shareholders. Nazca will bring to Nutris its experience in the development of growth projects in international family-owned companies, providing the necessary resources and tools to take advantage of market opportunities.
Grant Thornton and Pérez Llorca advised Nazca on this transaction, while CDI Global and VC BioLaw advised the founders.
Pérez-Llorca advised Nazca with a Corporate team formed by partner Carmen Reyna (pictured left), associates Gonzalo Sánchez-Quiñones (pictured right) and Diego Muro, and counsel Francisco León.